Drug-Related Side Effects and Adverse Reactions

"Drug-Related Side Effects and Adverse Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.

Descriptor ID	D064420
MeSH Number(s)	C25.100
Concept/Terms	Drug-Related Side Effects and Adverse Reactions Drug-Related Side Effects and Adverse Reactions Drug Related Side Effects and Adverse Reactions Side Effects of Drugs Drug Side Effects Drug Side Effect Effects, Drug Side Side Effect, Drug Side Effects, Drug Adverse Drug Reaction Adverse Drug Reactions Drug Reaction, Adverse Drug Reactions, Adverse Reactions, Adverse Drug Adverse Drug Event Adverse Drug Events Drug Event, Adverse Drug Events, Adverse Drug Toxicity Drug Toxicity Toxicity, Drug Drug Toxicities Toxicities, Drug

Below are MeSH descriptors whose meaning is more general than "Drug-Related Side Effects and Adverse Reactions".

Diseases [C]
Chemically-Induced Disorders [C25]
Drug-Related Side Effects and Adverse Reactions [C25.100]

Below are MeSH descriptors whose meaning is related to "Drug-Related Side Effects and Adverse Reactions".

Below are MeSH descriptors whose meaning is more specific than "Drug-Related Side Effects and Adverse Reactions".

Drug-Related Side Effects and Adverse Reactions
Akathisia, Drug-Induced
Anticholinergic Syndrome
Cardiotoxicity
Chemical and Drug Induced Liver Injury
Drug Hypersensitivity
Dyskinesia, Drug-Induced
Injection Site Reaction
Metabolic Side Effects of Drugs and Substances
Propofol Infusion Syndrome
Serotonin Syndrome

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug-Related Side Effects and Adverse Reactions" by people in this website by year, and whether "Drug-Related Side Effects and Adverse Reactions" was a major or minor topic of these publications.

Bar chart showing 91 publications over 21 distinct years, with a maximum of 10 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	1	2
2003	1	0	1
2004	2	1	3
2005	3	2	5
2006	0	3	3
2007	1	1	2
2008	2	3	5
2009	2	3	5
2010	0	3	3
2011	5	1	6
2012	4	4	8
2013	1	1	2
2014	1	1	2
2015	1	0	1
2016	4	2	6
2017	10	0	10
2018	6	3	9
2019	5	1	6
2020	4	0	4
2021	6	1	7
2022	1	0	1

Below are the most recent publications written about "Drug-Related Side Effects and Adverse Reactions" by people in Profiles.

McCarthy LM, Savage R, Dalton K, Mason R, Li J, Lawson A, Wu W, Sternberg SA, Byrne S, Petrovic M, Onder G, Cherubini A, O'Mahony D, Gurwitz JH, Pegreffi F, Rochon PA. ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People. Drugs Aging. 2022 10; 39(10):829-840.

View in: PubMed
Facon T, Kumar SK, Plesner T, Orlowski RZ, Moreau P, Bahlis N, Basu S, Nahi H, Hulin C, Quach H, Goldschmidt H, O'Dwyer M, Perrot A, Venner CP, Weisel K, Mace JR, Raje N, Tiab M, Macro M, Frenzel L, Leleu X, Ahmadi T, Wang J, Van Rampelbergh R, Uhlar CM, Tromp B, Delioukina M, Vermeulen J, Usmani SZ. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 11; 22(11):1582-1596.

View in: PubMed
Sternberg SA, Petrovic M, Onder G, Cherubini A, O'Mahony D, Gurwitz JH, Pegreffi F, Mason R, Akerman J, McCarthy L, Lawson A, Li J, Wu W, Rochon PA. Identifying key prescribing cascades in older people (iKASCADE): a transnational initiative on drug safety through a sex and gender lens-rationale and design. Eur Geriatr Med. 2021 06; 12(3):475-483.

View in: PubMed
Hanlon JT, Tjia J. Avoiding Adverse Drug Withdrawal Events When Stopping Unnecessary Medications According to the STOPPFrail Criteria. Sr Care Pharm. 2021 Mar 01; 36(3):136-141.

View in: PubMed
Liu F, Zheng X, Yu H, Tjia J. Neural Multi-Task Learning for Adverse Drug Reaction Extraction. AMIA Annu Symp Proc. 2020; 2020:756-762.

View in: PubMed
Mitra A, Rawat BPS, McManus D, Kapoor A, Yu H. Bleeding Entity Recognition in Electronic Health Records: A Comprehensive Analysis of End-to-End Systems. AMIA Annu Symp Proc. 2020; 2020:860-869.

View in: PubMed
Rawat BPS, Jagannatha A, Liu F, Yu H. Inferring ADR causality by predicting the Naranjo Score from Clinical Notes. AMIA Annu Symp Proc. 2020; 2020:1041-1049.

View in: PubMed
Johkoh T, Lee KS, Nishino M, Travis WD, Ryu JH, Lee HY, Ryerson CJ, Franquet T, Bankier AA, Brown KK, Goo JM, Kauczor HU, Lynch DA, Nicholson AG, Richeldi L, Schaefer-Prokop CM, Verschakelen J, Raoof S, Rubin GD, Powell C, Inoue Y, Hatabu H. Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper From the Fleischner Society. Chest. 2021 03; 159(3):1107-1125.

View in: PubMed
Naessens D, Cameron C, Hoaglin DC. Network Meta-analysis of Ulcerative Colitis Pharmacotherapies: Carryover Effects From Induction and Bias of the Results. Clin Gastroenterol Hepatol. 2021 10; 19(10):2219-2221.

View in: PubMed
Loftus EV, Feagan BG, Panaccione R, Colombel JF, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Vermeire S. Long-term safety of vedolizumab for inflammatory bowel disease. Aliment Pharmacol Ther. 2020 10; 52(8):1353-1365.

View in: PubMed

People

Explore

Similar Concepts

Top Journals